D. Western Therapeutics Institute, Inc. (4576.T)
JPY 118.0
(3.51%)
JPY 118.0
(3.51%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -812.41 Million JPY | -89.07% |
| 2022 | -429.68 Million JPY | -188.39% |
| 2021 | -148.99 Million JPY | 46.04% |
| 2020 | -276.1 Million JPY | -307.28% |
| 2019 | 133.2 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -320.85 Million JPY | 12.93% |
| 2024 Q2 | -199.84 Million JPY | 37.71% |
| 2023 Q4 | -368.49 Million JPY | -88.07% |
| 2023 Q3 | -195.93 Million JPY | -30.52% |
| 2023 Q2 | -150.12 Million JPY | -53.4% |
| 2023 Q1 | -97.86 Million JPY | 51.84% |
| 2023 FY | -812.41 Million JPY | -89.07% |
| 2022 FY | -429.68 Million JPY | -188.39% |
| 2022 Q3 | -115.98 Million JPY | 0.0% |
| 2022 Q4 | -203.21 Million JPY | -75.21% |
| 2021 FY | -148.99 Million JPY | 46.04% |
| 2020 FY | -276.1 Million JPY | -307.28% |
| 2019 FY | 133.2 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 311.565% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -54.183% |
| GNI Group Ltd. | 8.09 Billion JPY | 110.037% |
| Linical Co., Ltd. | 338.26 Million JPY | 340.169% |
| Trans Genic Inc. | 4.08 Million JPY | 19987.662% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 43.502% |
| Soiken Holdings Inc. | -662.2 Million JPY | -22.683% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 688.043% |
| AnGes, Inc. | -7.43 Billion JPY | 89.077% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | 36.931% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 88.706% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 535.156% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -4.155% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | 29.533% |
| CanBas Co., Ltd. | -1.2 Billion JPY | 32.803% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -151.006% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | 33.41% |
| Kidswell Bio Corporation | -1.42 Billion JPY | 42.872% |
| PeptiDream Inc. | 3.03 Billion JPY | 126.761% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 58.091% |
| Ribomic Inc. | -1.02 Billion JPY | 20.681% |
| SanBio Company Limited | -2.64 Billion JPY | 69.273% |
| Healios K.K. | -3.82 Billion JPY | 78.749% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | 30.449% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 45.461% |
| Delta-Fly Pharma, Inc. | -1.42 Billion JPY | 43.164% |
| StemRIM | -2.02 Billion JPY | 59.821% |
| CellSource Co., Ltd. | 923.14 Million JPY | 188.005% |
| FunPep Company Limited | -933.41 Million JPY | 12.964% |
| Kringle Pharma, Inc. | -854.15 Million JPY | 4.887% |
| Stella Pharma Corporation | -763.74 Million JPY | -6.371% |
| TMS Co., Ltd. | -960.04 Million JPY | 15.377% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | 28.106% |
| Cuorips Inc. | -632.18 Million JPY | -28.509% |
| K Pharma,Inc. | 260.33 Million JPY | 412.07% |
| Takara Bio Inc. | 1.48 Billion JPY | 154.893% |
| ReproCELL Incorporated | -31.41 Million JPY | -2486.061% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 3179.881% |
| StemCell Institute Inc. | 310.98 Million JPY | 361.241% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 667.449% |
| CellSeed Inc. | -846.53 Million JPY | 4.031% |